J. Martijn Kerst

The Netherlands Cancer Institute

Papers

1

Total Citations

16

H-Index

1

About

J. Martijn Kerst is a leading urologic oncologist whose research focuses on advancing minimally invasive surgical techniques for testicular cancer, particularly nonseminomatous germ cell tumors (NSGCT). His major contribution lies in demonstrating the feasibility and safety of robot-assisted residual mass resection (RA-RMR) for patients with post-chemotherapy residual tumors—a challenging procedure traditionally performed via open surgery. His most-cited work, a 2020 retrospective study analyzing outcomes across two tertiary centers (16 citations), provides critical evidence that RA-RMR can achieve effective oncologic control while reducing morbidity. This research has helped shift clinical practice toward robotic approaches in select cases, offering patients shorter recovery times without compromising cancer outcomes. Kerst’s work is notable for its practical impact on surgical decision-making in a rare but aggressive malignancy, and his findings continue to guide urologic surgeons in optimizing treatment for metastatic NSGCT survivors.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor
16 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: The Netherlands Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago